reports
Erasca Announces Closing of Upsized Public Offering of Common Stock, I...
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares SAN DIEGO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it has closed its previously announced upsized public offering of 25,875,000 shares of its common stock, including 3,375,000 shares sold pursuant to the underwriters’ full exercise ...
Erasca Announces Pricing of Upsized Public Offering of Common Stock
Erasca Announces Pricing of Upsized Public Offering of Common Stock SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an upsized public offering of 22,500,000 shares of its common stock. The shares of common stock are being sold to the public at a price of $10.00 per share. All of the shares of common stock to be sold in the public offering are to be sold by Erasca....
Erasca Announces Proposed Public Offering of $150 Million of Common St...
Erasca Announces Proposed Public Offering of $150 Million of Common Stock SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell, subject to market and other conditions, $150.0 million of shares of its common stock in a proposed underwritten public offering. All of the shares of common stock to be sold in the proposed offering are being offered by Eras...
Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-...
Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones Encouraging early clinical activity, including confirmed partial responses in multiple tumor types with different RAS mutations, coupled with promising safety and pharmacokinetics data, observed for ERAS-0015 during dose escalation Initial Phase 1 monotherapy data for ERAS-0015 (potential best-in-class pan-RAS molecular glue) planned for H1 2026 and for ERAS-4001 (potential first-in-class pan-KRAS inhibitor) planned for H2 2026 SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a...
Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference
Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the 44th Annual J.P. Morgan Healthcare Conference being held at the Westin St. Francis in San Francisco, California. Management will present on Tuesday, January 13, 2026, at 1:30 pm Pacific Time and will also participate in one-on-one invest...
Epsilon Energy Ltd. Announces the Divestment of Dewey Energy Holdings ...
Epsilon Energy Ltd. Announces the Divestment of Dewey Energy Holdings LLC and the Company’s Asset in the Anadarko Basin HOUSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced the signing of definitive transaction documents and the coincident closing of a sale of the Company’s wholly owned subsidiary, Dewey Energy Holdings, LLC, which holds the Company’s Western Anadarko basin assets, to an undisclosed private buyer. The assets sold included approximately 813 Mcfe/d (60% natural gas) of production (Q3 2025 figure) and app...
Epsilon Energy Ltd. Announces Quarterly Dividend
Epsilon Energy Ltd. Announces Quarterly Dividend HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that its Board of Directors has declared a dividend of $0.0625 per share of common stock (annualized $0.25/sh) to the shareholders of record at the close of business on December 15, 2025, payable on December 31, 2025. All dividends paid by the Company are “eligible dividends” as defined in subsection 89(1) of the Income Tax Act (Canada), unless indicated otherwise. About Epsilon Epsilon Energy Ltd. is a North American...
Erasca to Present at the 8th Annual Evercore Healthcare Conference
Erasca to Present at the 8th Annual Evercore Healthcare Conference SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the 8th Annual Evercore Healthcare Conference being held at the Loews Coral Gables Hotel in Coral Gables, FL. Management will participate in a fireside chat on Wednesday, December 3, 2025, at 10:25 am Eastern Time and will also participate in on...
Epsilon Announces the Issuance of Contingent Shares as Consideration f...
Epsilon Announces the Issuance of Contingent Shares as Consideration for the Acquisition of Peak BLM Lease LLC HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported the issuance of common shares as consideration in connection with the acquisition of Peak BLM Lease LLC, which closed on November 14, 2025. As contemplated by the membership interest purchase agreement for Peak BLM Lease LLC (“Purchase Agreement”), a copy of which was attached to the Company’s proxy statement filed with the Securities and Exchange Commission ...
Epsilon Announces the Closing of the Acquisitions of the Peak Companie...
Epsilon Announces the Closing of the Acquisitions of the Peak Companies With Assets in the Powder River Basin HOUSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported the consummation of the previously announced acquisitions of Peak Exploration and Production LLC and Peak BLM Lease LLC (together, the “Peak Companies”) (the “Closing”). The Closing followed a special meeting of the Company’s shareholders held on November 12, 2025, where the Company’s shareholders approved the issuance of common shares in connection with the a...
Erasca Reports Third Quarter 2025 Business Updates and Financial Resul...
Erasca Reports Third Quarter 2025 Business Updates and Financial Results U.S. composition of matter patent protection through 2043 for potential best-in-class pan-RAS molecular glue ERAS-0015 Strengthened scientific leadership with promotion of Robert Shoemaker, Ph.D., to chief scientific officer Initial Phase 1 monotherapy data for ERAS-0015 and pan-KRAS inhibitor ERAS-4001 expected in 2026 Robust balance sheet with cash, cash equivalents, and marketable securities of $362 million as of September 30, 2025 is expected to fund operations into H2 2028 SAN DIEGO, Nov. 12,...
Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular ...
Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015 The issued patent provides intellectual property protection for ERAS-0015 and related compositions until at least 2043 Initial Phase 1 monotherapy data for ERAS-0015 and pan-KRAS inhibitor ERAS-4001 expected in 2026 SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that the U.S. Patent and Tra...
First Horizon Corp: 1 director
A director at First Horizon Corp sold 155,149 shares at 21.312USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Epsilon Announces Third Quarter 2025 Results
Epsilon Announces Third Quarter 2025 Results HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported third quarter 2025 financial and operating results. Third Quarter 2025 Highlights: Epsilon - Q3 2025 Q3 2025Q2 2025Q3 2024QoQ%YoY%YTD 2025NRI Production GasMMcf2,1362,7521,304-22%64%7,628OilMbbl394453-11%-26%129NGLMbbl1481778%-18%38TotalMmcfe2,4563,0641,727-20%42%8,629DailyMmcfe/d26.733.718.8 31.6 Revenues$M Gas 4,7586,9101,904-31%150%22,282Oil 2,5112,7253,965-8%-37%8,505NGL 26714533584%-20%799Mid...
Erasca to Present at Upcoming Conferences in November
Erasca to Present at Upcoming Conferences in November SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences in November 2025 and will also participate in one-on-one investor meetings at each of these conferences. Guggenheim 2nd Annual Healthcare Innovation Conference (November 10-12, 2025)Location: Boston, MA Form...
Genie Energy Announces Third Quarter 2025 Results
Genie Energy Announces Third Quarter 2025 Results Newark, NJ , Nov. 03, 2025 (GLOBE NEWSWIRE) -- : Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the third quarter of 2025. Michael Stein, Chief Executive Officer of Genie Energy, commented: "Genie Energy achieved another quarter of double-digit topline growth to attain record third quarter revenue. The revenue increase was fueled by an increase in per meter electricity consumption, rising commodity prices, and RCE base growth at Genie Retail Energy (GRE). How...
- Jonathan Moreland
Epsilon Energy Ltd. Schedules Third Quarter 2025 Earnings Release and ...
Epsilon Energy Ltd. Schedules Third Quarter 2025 Earnings Release and Conference Call HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that it will issue its third quarter 2025 earnings release on Wednesday, November 5, 2025 after the market close and host a conference call to discuss its financial and operating results on Thursday, November 6, 2025 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time). Interested parties in the United States and Canada may participate toll-free by dialing (833) 816-1385. Internatio...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.